ELDN · ISSUER CIK 1404281
Eledon Pharmaceuticals, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 Eledon Pharmaceuticals, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Aug 4, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 202617:22 | Jul 31, 2026 | ELDN | Chief Executive Officer, Director | F · Tax | $3.38 | −194,791 | 168,663 | -54% | $658K | ||
| Aug 4, 202617:22 | Jul 31, 2026 | ELDN | Chief Executive Officer, Director | A · Grant | — | +354,454 | 363,454 | +3938% | — | ||
| Aug 4, 202617:22 | Jul 31, 2026 | ELDN | President, Director | F · Tax | $3.38 | −72,138 | 81,215 | -47% | $244K | ||
| Aug 4, 202617:22 | Jul 31, 2026 | ELDN | President, Director | A · Grant | — | +152,353 | 153,353 | +15235% | — |